The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.
 
Philippe Moreau
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
Asher Alban Akmal Chanan-Khan
No Relationships to Disclose
 
Andrew Warwick Roberts
Employment - Walter and Eliza Hall Institute of Medical Research
Research Funding - Abbvie; Genentech
 
Amit Agarwal
Consulting or Advisory Role - Amgen; Millennium
Speakers' Bureau - Celgene; Onyx
Research Funding - Abbvie
 
Thierry Facon
No Relationships to Disclose
 
Shaji Kumar
Honoraria - Skyline Diagnostics
Research Funding - Abbvie; Celgene; Janssen; Millennium; Onyx; Sanofi
 
Cyrille Touzeau
Research Funding - Abbvie (Inst)
 
Susan Diehl
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jaclyn Cordero
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jeremy A Ross
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Wijith Munasinghe
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Ming Zhu
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Ahmed H. Salem
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Joel Leverson
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Paulo Cesar Maciag
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Maria E. Verdugo
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Simon J Harrison
Speakers' Bureau - Janssen-Cilag
Research Funding - Abbvie; Janssen-Cilag